Etched Founder Joins, AI Creates Jobs, It's OVER for Peptides, Tristan Thompson in the Ultradome

Watch on YouTube ↗  |  June 30, 2026 at 21:06  |  2:59:24  |  TBPN
Speakers
John Coogan — Co-Host, TBPN
Gavin Uberti — Co-founder, Etched
Michael Anderson — Global Head of Credit Strategy, Citigroup
Tristan Thompson — Investor, NBA Champion
Larsen Jensen — Founder & GP, Harpoon Ventures; former Navy SEAL

Summary

The episode covers Rocket Lab's acquisition of Aridium, Comcast's planned split, AI job data, and FDA decisions on peptides and Zyn. It also features founder and investor interviews on AI inference hardware, crypto, robotics, defense tech, and several startup funding rounds. Main market implications include bullish AI semiconductor demand, crypto, robotics, and nicotine pouches, while peptide companies face regulatory risk.

  • Rocket Lab agrees to acquire Aridium for $8B, positioning itself as a vertically integrated space applications competitor to SpaceX.
  • Comcast plans to split its connectivity business from NBC Universal content.
  • A Ramp study finds high AI-adopting firms grow employment, countering AI job-loss narratives.
  • FDA recommends against adding seven peptides to the 503A bulks list, a negative for peptide companies.
  • Zyn receives FDA modified risk tobacco product approval, a positive for nicotine pouches.
  • Etched CEO Gavin Uberti discusses AI inference hardware, low-voltage inference, cluster-scale memory, and semiconductor supply-chain demand.
  • Framework Ventures remains bullish on crypto and sees MicroStrategy blow-up narratives as overblown.
  • Tristan Thompson discusses physical AI and robotics, especially in agriculture and business efficiency.
Ideas
John Coogan Co-Host, TBPN 6:37
Rocket Lab acquisition unlocks space applications
Rocket Lab's $8B acquisition of Aridium gives it spectrum, an operational constellation, profitable satellite operations, and vertical integration with its own launch and spacecraft manufacturing. The deal positions Rocket Lab to compete directly with SpaceX in space applications, and the host says the deal makes a ton of sense and space bulls will be picking up shares.
Gavin Uberti Co-founder, Etched 67:33
AI inference demand drives semiconductor buildout
AI inference demand is far larger than people realize because frontier model access must expand from a couple million people to 8 billion people, plus AI agents. That requires vastly more tokens, bigger assembly lines, more factories, and new technology across the semiconductor supply chain.
John Coogan Co-Host, TBPN 76:04
FDA opposes peptides; peptide companies hurt
FDA recommends against adding all seven reviewed peptides to the 503A bulks list, effectively banning legal human use and killing the gray market. Real companies that entered the peptide space in anticipation of regulatory change face a serious hit.
John Coogan Co-Host, TBPN 79:02
Zyn MRTP approval boosts nicotine pouches
Zyn received FDA modified risk tobacco product approval, the first in the nicotine pouch category. This lets Zyn market itself as better than cigarettes, which is a very high regulatory bar and a major positive for the industry.
Michael Anderson Global Head of Credit Strategy, Citigroup 128:57
Saylor's strategy will eventually be proven right
Michael Saylor's financial engineering around convertible, preferred, and common layers is viewed by Anderson as less fragile than the bear narrative suggests. He says the blowing-up narratives are overblown and Saylor will eventually be proven right, though it may take years.
Tristan Thompson Investor, NBA Champion 155:18
Physical AI robotics improves business efficiency
Tristan is bullish on physical AI and robotics, especially for agriculture, healthcare, construction, and landscaping. He argues autonomous machines and robotics improve business efficiency by reducing reliance on labor and helping owners focus on business growth.
Up Next

This TBPN video, published June 30, 2026, features John Coogan, Gavin Uberti, Michael Anderson, Tristan Thompson discussing RKLB, SMH, Peptide companies, PM, MSTR, ROBO. 6 trade ideas extracted by AI with direction and confidence scoring.

Speakers: John Coogan, Gavin Uberti, Michael Anderson, Tristan Thompson  · Tickers: RKLB, SMH, Peptide companies, PM, MSTR, ROBO